Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127,957 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers.
Abaza Y, Winer ES, Murthy GSG, Shallis RM, Matthews AH, Badar T, Geramita EM, Kota VK, Swaroop A, Doukas P, Bradshaw D, Helenowski IB, Liu Y, Zhang H, Im A, Litzow MR, Perl AE, Atallah E, Altman JK. Abaza Y, et al. Among authors: zhang h. Am J Hematol. 2024 Apr;99(4):606-614. doi: 10.1002/ajh.27231. Epub 2024 Feb 11. Am J Hematol. 2024. PMID: 38342997
Lung Cancer Survival in Patients With Autoimmune Disease.
Jacob S, Rahbari K, Tegtmeyer K, Zhao J, Tran S, Helenowski I, Zhang H, Walunas T, Varga J, Dematte J, Villaflor V. Jacob S, et al. Among authors: zhang h. JAMA Netw Open. 2020 Dec 1;3(12):e2029917. doi: 10.1001/jamanetworkopen.2020.29917. JAMA Netw Open. 2020. PMID: 33315114 Free PMC article.
Therapy-related myeloid neoplasms with normal karyotype show distinct genomic and clinical characteristics compared to their counterparts with abnormal karyotype.
Tariq H, Barnea Slonim L, Coty Fattal Z, Alikhan MB, Segal J, Gurbuxani S, Helenowski IB, Zhang H, Sukhanova M, Lu X, Altman JK, Chen QC, Behdad A. Tariq H, et al. Among authors: zhang h. Br J Haematol. 2022 Jun;197(6):736-744. doi: 10.1111/bjh.18154. Epub 2022 Mar 18. Br J Haematol. 2022. PMID: 35304738
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial.
Sonabend AM, Gould A, Amidei C, Ward R, Schmidt KA, Zhang DY, Gomez C, Bebawy JF, Liu BP, Bouchoux G, Desseaux C, Helenowski IB, Lukas RV, Dixit K, Kumthekar P, Arrieta VA, Lesniak MS, Carpentier A, Zhang H, Muzzio M, Canney M, Stupp R. Sonabend AM, et al. Among authors: zhang dy, zhang h. Lancet Oncol. 2023 May;24(5):509-522. doi: 10.1016/S1470-2045(23)00112-2. Lancet Oncol. 2023. PMID: 37142373 Free PMC article. Clinical Trial.
Urologists and Lesbian, Gay, Bisexual, Transgender, or Queer Patients: A Survey-based Study of the Practice Patterns, Attitudes, and Knowledge Base of Urologists Toward Their Lesbian, Gay, Bisexual, Transgender, or Queer Patients.
Xu AJ, Panken EJ, Gonzales-Alabastro CD, Zhang H, Helenowski IB, Murphy AB, Prabhu R, Amarasekera C. Xu AJ, et al. Among authors: zhang h. Urology. 2023 Sep;179:71-79. doi: 10.1016/j.urology.2023.05.019. Epub 2023 Jun 5. Urology. 2023. PMID: 37286139
AUTHOR REPLY.
Xu AJ, Panken EJ, Gonzales-Alabastro CD, Zhang H, Helenowski IB, Murphy AB, Prabhu R, Amarasekera C. Xu AJ, et al. Among authors: zhang h. Urology. 2023 Sep;179:78-79. doi: 10.1016/j.urology.2023.05.020. Epub 2023 Jul 16. Urology. 2023. PMID: 37455201 No abstract available.
Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer in Patients Treated with Neoadjuvant Chemotherapy.
Vitello DJ, Shah D, Wells A, Masnyk L, Cox M, Janczewski LM, Abad J, Dawravoo K, D'Souza A, Suh G, Bayer R, Cristofanilli M, Bentrem D, Liu Y, Zhang H, Santana-Santos L, Jennings LJ, Zhang Q, Chawla A. Vitello DJ, et al. Among authors: zhang q, zhang h. Ann Surg. 2024 Oct 14. doi: 10.1097/SLA.0000000000006562. Online ahead of print. Ann Surg. 2024. PMID: 39471087
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics.
Kumthekar PU, Avram MJ, Lassman AB, Lin NU, Lee E, Grimm SA, Schwartz M, Bell Burdett KL, Lukas RV, Dixit K, Perron I, Zhang H, Gradishar WJ, Pentsova EI, Jeyapalan S, Groves MD, Melisko M, Raizer JJ. Kumthekar PU, et al. Among authors: zhang h. Neuro Oncol. 2023 Mar 14;25(3):557-565. doi: 10.1093/neuonc/noac195. Neuro Oncol. 2023. PMID: 35948282 Free PMC article. Clinical Trial.
127,957 results
You have reached the last available page of results. Please see the User Guide for more information.